A potential change regarding how the NFL schedules — or, more specifically, flexes — its Thursday Night Football games could ...

NFL owners will be asked to vote Monday on a measure that would potentially give teams one less week’s notice if a scheduled ...

TNF Pharmaceuticals (TNFA) announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was presented last week in a podium session at the peer ...

TNF inhibitor use demonstrates no negative impact on survival among patients recently diagnosed with colorectal, lung or ...

The following is a summary of “Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

People with inflammatory bowel disease (IBD) or Parkinson’s disease have depletions in similar types of beneficial bacteria, ...

TNF Pharmaceuticals (TNFA) announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...

Silent Crohn’s disease may have little or no symptoms. It's important to monitor disease activity and treat the condition to ...